MedTrace Logo

Donepezil in Preventing Delirium in Hospitalized Elderly

NCT00182884 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2008-03-03

No results posted yet for this study

Summary

The purpose of this study is to explore the efficacy of a perioperative daily dose of Donepezil (a cholinergic enhancer) in reducing the incidence and severity of delirium.

Conditions

  • Postoperative Complications
  • Delirium

Interventions

DRUG

Donepezil

Sponsors & Collaborators

  • Indiana University Health

    lead OTHER

Principal Investigators

  • Malaz Boustani, MD, MPH · Regenstrief Institute, Indiana University Center for Aging Research

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-07-31
Primary Completion
2007-04-30
Completion
2007-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00182884 on ClinicalTrials.gov